Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Pharmaniaga Bhd's Enterprise Value is RM2,129 Mil.
Pharmaniaga Bhd's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was RM-99 Mil. Therefore, Pharmaniaga Bhd's EV-to-FCF for today is -21.50.
The historical rank and industry rank for Pharmaniaga Bhd's EV-to-FCF or its related term are showing as below:
XKLS:7081'
s EV-to-FCF Range Over the Past 10 Years
Min: -8573.7 Med: -14.83 Max: 511
Current: -21.63
During the past 13 years, the highest EV-to-FCF of Pharmaniaga Bhd was 511.00. The lowest was -8573.70. And the median was -14.83.
XKLS:7081's EV-to-FCF is ranked worse than 100% of 69
companies
in the Medical Distribution industry
Industry Median: 16.01
vs XKLS:7081: -21.63
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Pharmaniaga Bhd's PE Ratio (TTM) for today is calculated as:
Pharmaniaga Bhd's share price for today is RM1.16.
Pharmaniaga Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.057.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Pharmaniaga Bhd EV-to-FCF Related Terms
Pharmaniaga Bhd EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Pharmaniaga Bhd's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Pharmaniaga Bhd's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharmaniaga Bhd EV-to-FCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Pharmaniaga Bhd's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Pharmaniaga Bhd's EV-to-FCF falls into.
Pharmaniaga Bhd's current Enterprise Value is RM2,129 Mil.
Pharmaniaga Bhd's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM-99 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharmaniaga Bhd (XKLS:7081) has a EV-to-FCF of -21.50 as of Aug. 06, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Pharmaniaga Bhd and its competitors. According to the industry distribution chart, Pharmaniaga Bhd ranks #999999 out of 69 companies in the Medical Distribution industry.
Is Pharmaniaga Bhd's EV-to-FCF too high?
Pharmaniaga Bhd's current EV-to-FCF is -21.50. Based on the distribution chart, Pharmaniaga Bhd ranks #999999 out of 69 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Pharmaniaga Bhd has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pharmaniaga Bhd's EV-to-FCF compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Pharmaniaga Bhd ranks #999999 out of 69 companies for EV-to-FCF. This places Pharmaniaga Bhd in the lower half of its industry. The industry median EV-to-FCF is 16.01. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Distribution company?
The median EV-to-FCF among Medical Distribution companies is 16.01, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Pharmaniaga Bhd and its competitors. For the Medical Distribution industry, the median EV-to-FCF is 16.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pharmaniaga Bhd's current EV-to-FCF is -21.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmaniaga Bhd stock overvalued right now?
Based on GuruFocus' analysis, Pharmaniaga Bhd (XKLS:7081) is currently considered Significantly Overvalued. The stock's GF Value™ is RM0.70, compared to a current price of RM1.16 — trading 65.7% above its estimated fair value. The current EV-to-FCF is -21.50. Pharmaniaga Bhd's overall GF Score™ is 46/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Pharmaniaga Bhd (XKLS:7081), the current EV-to-FCF is -21.50 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pharmaniaga Bhd (XKLS:7081) Overvalued in 2026?
Based on GuruFocus' analysis, Pharmaniaga Bhd stock appears to be overvalued.
The current stock price of RM1.16 is trading 65.7% above its estimated GF Value™ of RM0.70.
GuruFocus considers Pharmaniaga Bhd to be Significantly Overvalued.
Key valuation signals for XKLS:7081:
EV-to-FCF: -21.50
GF Value™: RM0.70 vs. price of RM1.16 (65.7% above fair value)
No single metric tells the full story. See the XKLS:7081 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Pharmaniaga Bhd is engaged in the manufacture of pharmaceuticals and medical devices. The company is also involved in logistics and distribution. The group operates in three segments - Logistics and distribution, Manufacturing in Malaysia, and Manufacturing and distribution in Indonesia. Maximum revenue is generated by the logistics and distribution segment in Malaysia. The Logistics and distribution segment is engaged in distribution, trading and wholesaling of pharmaceutical and medical products as well as supply and installation of medical and hospital equipment in Malaysia.
46GF Score
Get the complete analysis for XKLS:7081
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7081 has been successfully added to your 
